₹325.00 19.40 (6.35%)
16:01 PM, 12-Mar-2025BSE : 532523
NSE : BIOCON
Sector : Health care
ISIN Code : INE376G01013
Last Updated: 12-Mar-2025 | 04:01 PM IST
Market Cap (₹ Cr) | 39,020 |
Traded Value (₹ Cr) | 3.20 |
Volume (Shares) | 98,570 |
Face Value (₹) | 5 |
52-Week High (₹) | 404.60 |
52-Week High Date | 21-Jan-2025 |
52-Week Low (₹) | 260.00 |
52-Week Low Date | 19-Apr-2024 |
All Time High (₹) | 487.70 |
All Time High Date | 23-Dec-2020 |
All Time Low (₹) | 14.42 |
All Time Low Date | 28-Nov-2008 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 39,020 |
EPS - TTM (₹) [C] | 6.44 |
P/E Ratio (X) [C] | 50.47 |
Face Value (₹) | 5 |
Latest Dividend (%) | 10.00 |
Latest Dividend Date | 30-Jun-2022 |
Dividend Yield (%) | 0.15 |
Book Value Share (₹) [C] | 174.85 |
P/B Ratio (₹) [C] | 1.86 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
SBI Contra Fund (IDCW) | 590.41 | 1,95,20,774 | 1.49 |
SBI Contra Fund (G) | 590.41 | 1,95,20,774 | 1.49 |
SBI Contra Fund - Direct (G) | 590.41 | 1,95,20,774 | 1.49 |
SBI Contra Fund - Direct (IDCW) | 590.41 | 1,95,20,774 | 1.49 |
Kotak Equity Opportunities (G) | 393.19 | 1,30,00,000 | 1.72 |
Kotak Equity Opportunities - Direct (G) | 393.19 | 1,30,00,000 | 1.72 |
SBI Balanced Advantage Fund (G) | 303.09 | 1,00,21,205 | 0.93 |
SBI Balanced Advantage Fund (IDCW) | 303.09 | 1,00,21,205 | 0.93 |
SBI Balanced Advantage Fund - Direct (G) | 303.09 | 1,00,21,205 | 0.93 |
SBI Balanced Advantage Fund - Direct (IDCW) | 303.09 | 1,00,21,205 | 0.93 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
13-Jan-2025 | Motilal Oswal | Buy | - | |
12-Aug-2024 | ICICI Securities | Sell | - | |
18-May-2024 | ICICI Securities | Sell | - |
Today's Low/High (₹) | 323.45 330.55 |
Week Low/High (₹) | 229.70 330.55 |
Month Low/High (₹) | 229.70 330.55 |
Year Low/High (₹) | 260.00 405.00 |
All time Low/High (₹) | 14.42 488.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 38.00% | 38.05% | 22.97% | 27.64% |
1 Month | 23.36% | 23.42% | 19.03% | 23.24% |
3 Month | 16.18% | 16.21% | 19.93% | 24.47% |
6 Month | 5.37% | 5.42% | 25.04% | 29.23% |
1 Year | -17.19% | -17.21% | 24.11% | 27.96% |
3 Year | 8.80% | 8.91% | 82.98% | 91.93% |
Executive Chairman : Kiran Mazumdar Shaw
Director : Ravi Mazumdar
Independent Director : Vijay Kumar Kuchroo
Independent Director : M Damodaran
Independent Director : Bobby Parikh
Company Secretary : Mayank Verma
Managing Director & CEO : SIDDHARTH MITTAL
Director : Eric Vivek Mazumdar
Independent Director : Naina Lal Kidwai
Registered Office: 20th KM Hosur Road Hebbagodi, Electronic City P O,Bangalore,Karnataka-560100 Ph: 91-80-28082808
Email:co.secretary@biocon.com
1. What's the Biocon Ltd share price today?
Biocon Ltd share price was Rs 325.00 at 16:01 PM IST on 12th Mar 2025. Biocon Ltd share price was up by 6.35% over the previous closing price of Rs 305.60. Biocon Ltd share price trend:
2. How can I quickly analyse the performance of the Biocon Ltd stock?
The performance of the Biocon Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Biocon Ltd?
Biocon Ltd has a market capitalisation of Rs 39,020 crore.
4. What is Biocon Ltd's 52-week high/low share price?
The Biocon Ltd’s 52-week high share price is Rs 404.60 and 52-week low share price is Rs 260.00.
5. Is the Biocon Ltd profitable?
On a consolidated basis, Biocon Ltd reported a profit of Rs 81.10 crore on a total income of Rs 3,874.30 crore for the quarter ended 2024. For the year ended 2024, Biocon Ltd had posted a profit of Rs 1,297.80 crore on a total income of Rs 14,755.70 crore.
6. Which are Biocon Ltd’s peers in the Health care sector?
Biocon Ltd’s top 5 peers in the Health care sector are Alkem Lab, Glaxosmi. Pharma, Glenmark Pharma., Biocon, Ipca Labs., Ajanta Pharma, Laurus Labs.
7. Who owns how much in Biocon Ltd?
Key changes to the Biocon Ltd shareholding are as follows: